(210) | Number of the EPO application | 17746025 |
(220) | Filing date of the EPO application | 2017.07.20 |
(80) | EPO patent specification publication (B) | EPB nr. 35/2021, 2021.09.01 |
(110) | EPO patent number | 3487493 |
(21) | Number of the application | e 2021 0224 |
(71) | Name(s) of applicant(s), code of the country | ObsEva S.A., CH; |
(72) | Name(s) of inventor(s), code of the country | LOUMAYE Ernest, CH; GOTTELAND Jean-Pierre, CH; |
(73) | Name(s) of owner(s), code of the country | ObsEva S.A., CH; |
(54) | Title of the invention | OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE |
(13) | Kind-of-document code | A1 |
(51) | International Patent Classification | A61K 31/57 (2006.01.01); A61K 31/40 (2006.01.01); A61P 5/10 (2006.01.01); A61K 38/22 (2006.01.01); A61P 15/08 (2006.01.01) |
(19) | Country | CH |
(41) | Date of publication of the application | 2021.04.30 |
(30) | Priority | 201662365147 P, 2016.07.21, US; 201762527721 P, 2017.06.30, US |
(86) | International application | PCT/EP2017/068378, 2017.07.20 |
(87) | International publication | WO 2018/015497, 2018.01.25 |